New Risk • Jul 02
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.5% average weekly change). Shareholders have been substantially diluted in the past year (248% increase in shares outstanding). Revenue is less than US$1m (₹350k revenue, or US$3.7k). Minor Risk Market cap is less than US$100m (₹5.61b market cap, or US$59.1m). Board Change • Jun 03
No independent directors There are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Additional Director Poonam Chaturvedi is the most experienced director on the board, commencing their role in 2026. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors. Announcement • May 22
CCME Global Limited to Report Q4, 2026 Results on May 29, 2026 CCME Global Limited announced that they will report Q4, 2026 results on May 29, 2026 New Risk • Mar 27
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 248% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (248% increase in shares outstanding). Revenue is less than US$1m. Minor Risks Share price has been volatile over the past 3 months (9.0% average weekly change). Market cap is less than US$100m (₹4.57b market cap, or US$48.2m). Announcement • Mar 27
Genesis IBRC India Limited announced that it has received INR 322.5 million in funding from Dhanesha Advisory LLP On March 26, 2026, Genesis IBRC India Limited closed the transaction. The company approved the allotment of 32,250,000 equity shares at an issue price of INR 10 per equity share for gross proceeds of INR 322,500,000. The transaction included participation from 11 investors, including Padmanaban Krishnamoorthy for 20,000,000 equity shares, V. Varalakshmi for 4,000,000 equity shares, Noor Muhammed Habibullah, Suresh Kumar Ramani, and Vidhu Mohan Pillai for 2,000,000 equity shares each, Dhanesh Advisory LLP for 1,100,000 equity shares, Ajay Sangani for 200,000 equity shares, Kaushal Ruparel for 700,000 equity shares, Nandlal Chaturvedi for 100,000 equity shares, Poonam Chaturvedi for 50,000 equity shares, and Ravindranath Rajaram for 100,000 equity shares. New Risk • Feb 12
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹900.9m (US$9.95m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m. Market cap is less than US$10m (₹900.9m market cap, or US$9.95m). Minor Risk Share price has been volatile over the past 3 months (7.8% average weekly change). Announcement • Feb 11
Genesis IBRC India Limited to Report Q3, 2026 Results on Feb 14, 2026 Genesis IBRC India Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 14, 2026 Announcement • Jan 29
Genesis IBRC India Limited announced that it expects to receive INR 402.5 million in funding from Dhanesha Advisory LLP Genesis IBRC India Limited announced private placement to offer, issue and allot up to 40,250,000 equity shares at a face value of INR 10 at an issue price of INR 10 for gross proceeds of INR 402,500,000 on January 28, 2026. The transaction includes participation from Padmanaban Krishnamoorthy, V. Varalakshmi, Muhammed Noor Habibullah, Suresh Kumar Ramani, Vidhu Mohan Pillai, Dhanesh Advisory LLP, Ajay Sangani, Kaushal Ruparel, Nandlal Chaturvedi, Poonam Chaturvedi, Ravindranath Rajaram. The company will issue share on preferential basis. The transaction is approved by board of directors of the company and is subject to shareholders, stock exchange and other requisite authorities’ approval. Announcement • Jan 09
Padmanaban Krishnamoorthy and V Varalakshmi completed the acquisition of 11.33% stake in Genesis IBRC India Limited (BSE:514336) from Mastan Rao Pesla, Pesala Srikanth, Pesla Arun Kumar and Venkata Subbamma Pesala. Padmanaban Krishnamoorthy and V Varalakshmi agreed to acquire 11.33% stake in Genesis IBRC India Limited (BSE:514336) from Mastan Rao Pesla, Pesala Srikanth, Pesla Arun Kumar and Venkata Subbamma Pesala for INR 10.3 million on March 6, 2025. A cash consideration of INR 10.31 million valued at INR 7 per share will be paid by the buyer. As part of consideration, INR 10.31 million is paid towards common equity of Genesis IBRC India Limited. The transaction is subject to approval by regulatory board / committee and subject to statutory approval.
Padmanaban Krishnamoorthy and V Varalakshmi completed the acquisition of 11.33% stake in Genesis IBRC India Limited (BSE:514336) from Mastan Rao Pesla, Pesala Srikanth, Pesla Arun Kumar and Venkata Subbamma Pesala on December 8, 2025. New Risk • Dec 02
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m. Minor Risks Share price has been volatile over the past 3 months (7.2% average weekly change). Market cap is less than US$100m (₹1.69b market cap, or US$18.7m). Announcement • Nov 05
Genesis IBRC India Limited to Report Q2, 2026 Results on Nov 14, 2025 Genesis IBRC India Limited announced that they will report Q2, 2026 results on Nov 14, 2025 Valuation Update With 7 Day Price Move • Oct 04
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ₹78.98, the stock trades at a trailing P/E ratio of 29.5x. Average trailing P/E is 61x in the Biotechs industry in India. Total returns to shareholders of 398% over the past year. Valuation Update With 7 Day Price Move • Sep 11
Investor sentiment improves as stock rises 28% After last week's 28% share price gain to ₹48.53, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 64x in the Biotechs industry in India. Total returns to shareholders of 364% over the past three years. Board Change • Sep 05
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Whole Time Chairperson Balakrishna Koppula was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Sep 01
Genesis IBRC India Limited, Annual General Meeting, Sep 30, 2025 Genesis IBRC India Limited, Annual General Meeting, Sep 30, 2025. Valuation Update With 7 Day Price Move • Aug 13
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹34.51, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 54x in the Biotechs industry in India. Total returns to shareholders of 213% over the past three years. Announcement • Aug 09
Genesis IBRC India Limited to Report Q1, 2026 Results on Aug 14, 2025 Genesis IBRC India Limited announced that they will report Q1, 2026 results on Aug 14, 2025 Valuation Update With 7 Day Price Move • Jul 23
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹27.05, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 55x in the Biotechs industry in India. Total returns to shareholders of 177% over the past three years. Board Change • Jul 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Whole Time Chairperson Balakrishna Koppula was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Jun 09
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Whole Time Chairperson Balakrishna Koppula was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • May 21
Genesis IBRC India Limited to Report Q4, 2025 Results on May 29, 2025 Genesis IBRC India Limited announced that they will report Q4, 2025 results on May 29, 2025 Board Change • Apr 21
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Whole Time Chairperson Balakrishna Koppula was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Apr 07
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Whole Time Chairperson Balakrishna Koppula was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Mar 07
V Varalakshmi acquired 55.92% stake in Genesis IBRC India Limited (BSE:514336) from Naga Kanaka Durga Prasad Chalavadi, Raparla Jayabharathi, Dcrypt Technologies Private Limited and Diligent Industries Limited (BSE:531153) for INR 50.9 million. V Varalakshmi acquired 55.92% stake in Genesis IBRC India Limited (BSE:514336) from Naga Kanaka Durga Prasad Chalavadi, Raparla Jayabharathi, Dcrypt Technologies Private Limited and Diligent Industries Limited (BSE:531153) for INR 50.9 million on March 6, 2025. The deal was executed via a Depository Instruction Slip in favor of V Varalakshmi. A cash consideration of INR 50.89 million valued at INR 7 per share will be paid by the buyer. As part of consideration, INR 50.89 million is paid towards common equity of Genesis IBRC India Limited. The transaction is subject to approval by regulatory board / committee and subject to statutory approval.
V Varalakshmi completed the acquisition of 55.92% stake in Genesis IBRC India Limited (BSE:514336) from Naga Kanaka Durga Prasad Chalavadi, Raparla Jayabharathi, Dcrypt Technologies Private Limited and Diligent Industries Limited (BSE:531153) on March 6, 2025. Board Change • Feb 17
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Whole Time Chairperson Balakrishna Koppula was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Feb 07
Genesis IBRC India Limited to Report Q3, 2025 Results on Feb 14, 2025 Genesis IBRC India Limited announced that they will report Q3, 2025 results on Feb 14, 2025 New Risk • Nov 16
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -₹298k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹298k free cash flow). Shares are highly illiquid. Earnings have declined by 73% per year over the past 5 years. Revenue is less than US$1m (₹37m revenue, or US$434k). Market cap is less than US$10m (₹216.3m market cap, or US$2.56m). Announcement • Nov 05
Genesis IBRC India Limited to Report Q2, 2025 Results on Nov 14, 2024 Genesis IBRC India Limited announced that they will report Q2, 2025 results on Nov 14, 2024 Board Change • Oct 21
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Whole Time Chairperson Balakrishna Koppula was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Aug 19
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Whole Time Chairperson Balakrishna Koppula was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Aug 16
Genesis IBRC India Limited, Annual General Meeting, Sep 28, 2024 Genesis IBRC India Limited, Annual General Meeting, Sep 28, 2024. Announcement • Aug 06
Genesis IBRC India Limited to Report Q1, 2025 Results on Aug 14, 2024 Genesis IBRC India Limited announced that they will report Q1, 2025 results on Aug 14, 2024 Board Change • Jul 04
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Whole Time Chairperson Balakrishna Koppula was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Aug 03
Genesis IBRC India Limited to Report Q1, 2024 Results on Aug 08, 2023 Genesis IBRC India Limited announced that they will report Q1, 2024 results on Aug 08, 2023 Announcement • May 14
Genesis IBRC India Limited to Report Q4, 2023 Results on May 22, 2023 Genesis IBRC India Limited announced that they will report Q4, 2023 results on May 22, 2023 Announcement • Nov 07
Genesis IBRC India Limited to Report First Half, 2023 Results on Nov 14, 2022 Genesis IBRC India Limited announced that they will report first half, 2023 results on Nov 14, 2022 Announcement • Nov 01
Genesis IBRC India Limited Announces Resignation of Sridhar Pentela as Company Secretary / Compliance Officer Genesis IBRC India Limited announced that Mr. Sridhar Pentela has resigned from the office of Company Secretary of the Company with effect from closing hours on 31st October, 2022. Consequent to his resignation as Company Secretary of the Company, he also ceases to be the Compliance Officer of the Company. Announcement • Sep 07
Genesis IBRC India Limited, Annual General Meeting, Sep 30, 2022 Genesis IBRC India Limited, Annual General Meeting, Sep 30, 2022, at 11:00 Indian Standard Time. Location: Company at 241/2 & 389/2, Dwaraka Tirumala Road, Denduluru Village and Mandal - 534432 West Godavari Andhra Pradesh India Agenda: To consider and adopt the Audited Financial Statement of the Company for the financial year 2021-22 together with the Report of the Board of Directors and Auditors thereon; to appoint a Director in place of Mr. Balakrishna Koppula who retires by rotation and being eligible, offer himself for reappointment as Director;and to consider other matters. Announcement • Sep 04
Genesis IBRC India Limited Appoints Sridhar Pentela as Company Secretary and Compliance Officer The board of directors of Genesis IBRC India Limited meeting held on September 3, 2022 appointed Mr. Sridhar Pentela to the office of Company Secretary and Compliance officer of the Company with immediate effect. Sridhar Pentela educational qualifications include: Institute of Company secretary of India and MBA (HR & marketing) from Acharya Nagarjuna University. Work Experience as a company secretary: Shirdi sai electricals Ltd. from July to December 2018. Stylam Industries Ltd. from Jan to April 2019. NSPR Construction Pvt Ltd. from Oct 2019 to August 2022. Announcement • Aug 03
Genesis IBRC India Limited to Report Q1, 2023 Results on Aug 10, 2022 Genesis IBRC India Limited announced that they will report Q1, 2023 results on Aug 10, 2022 Announcement • Apr 09
Genesis Ibrc India Limited Announces Resignation of Ashok Amara as Company Secretary Genesis IBRC India Limited announced resignation of Ashok Amara as Company Secretary of the company with effect from April 8, 2022. Board Change • Dec 14
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Non-Executive Women Director Vanitha Nagulavari is the most experienced director on the board, commencing their role in 2019. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Board Change • Nov 09
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Non-Executive Women Director Vanitha Nagulavari is the most experienced director on the board, commencing their role in 2019. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Board Change • Sep 22
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Non-Executive Women Director Vanitha Nagulavari is the most experienced director on the board, commencing their role in 2019. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Announcement • Feb 05
Genesis IBRC India Limited to Report Q3, 2021 Results on Feb 12, 2021 Genesis IBRC India Limited announced that they will report Q3, 2021 results on Feb 12, 2021 Announcement • Nov 07
Genesis IBRC India Limited to Report Q2, 2021 Results on Nov 13, 2020 Genesis IBRC India Limited announced that they will report Q2, 2021 results on Nov 13, 2020 Announcement • Sep 30
Genesis IBRC India Limited Approves Appointment of Mr. Karamsetty Ratnakara Rao as Whole Time Director Genesis IBRC India Limited at AGM held on September 28, 2020 approved appointment of Mr. Karamsetty Ratnakara Rao as a Whole Time Director of the company. Announcement • Sep 08
Genesis IBRC India Limited to Report Q1, 2021 Results on Sep 15, 2020 Genesis IBRC India Limited announced that they will report Q1, 2021 results on Sep 15, 2020 Announcement • Jun 28
Genesis IBRC India Limited to Report Q4, 2020 Results on Jun 30, 2020 Genesis IBRC India Limited announced that they will report Q4, 2020 results on Jun 30, 2020